About this trial
Postpartum depression (PPD) is a frequent complication of the postnatal period but remains underdetected in routine clinical practice. This prospective clinical study, conducted at the high-risk pregnancy clinic of the CHUM, aims to estimate the prevalence of PPD among patients seen in postpartum follow-up. It also assesses the feasibility of implementing a standardized screening protocol that combines the administration of the Edinburgh Postnatal Depression Scale (EPDS) with a clinical decision-support algorithm to guide appropriate medical follow-up. The study also seeks to explore clinical characteristics associated with higher EPDS scores.
Eligibility criteria
Qualifiers
Patients aged 18 years or more
Patient who gave birth within the last 4 weeks to 6 months
Ability to understand French or English and complete the EPDS questionnaire
Physically present at their post-partum visit at the clinic
Disqualifiers
Inability to comprehend and/or complete the EPDS
Declines participation or does not provide informed consent
Trial design
Treatments tested in this trial
- Not listed